Hybrid coronary revascularization for multivessel coronary artery disease

Area of Science:

• Cardiovascular Surgery
• Interventional Cardiology
• Medical Technology

Background:

• Coronary artery disease (CAD) management often involves complex revascularization strategies.
• Conventional treatments like coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have limitations for multivessel disease.
• Hybrid coronary revascularization (HCR) emerged to address these limitations by integrating surgical and interventional techniques.

Purpose of the Study:

• To provide a comprehensive overview of hybrid coronary revascularization.
• To discuss patient selection criteria and procedural techniques for HCR.
• To review existing literature on the outcomes of HCR in multivessel CAD.

Main Methods:

• Literature review of studies on hybrid coronary revascularization.
• Analysis of patient selection, surgical techniques (e.g., LIMA to LAD grafting), and interventional approaches for non-LAD vessels.
• Synthesis of early and midterm outcome data from available retrospective studies.

Main Results:

• Hybrid coronary revascularization demonstrates feasibility and attractive outcomes in selected patients with multivessel CAD.
• Initial results suggest favorable early to midterm outcomes, combining surgical graft durability with interventional flexibility.
• The approach aims for complete revascularization, offering an individualized treatment strategy.

Conclusions:

• Hybrid coronary revascularization presents a viable alternative to conventional CABG and PCI for specific patient groups with multivessel CAD.
• Further research with larger sample sizes and prospective designs is needed to solidify the long-term efficacy and safety of HCR.
• HCR advances personalized medicine in treating complex heart disease.